Vtama and Zoryve Will Be the Latest Topicals for Psoriasis
October 2022
Vtama (tapinarof) and Zoryve (roflumilast) will be two new once-daily Rx creams for psoriasis.
Both will be touted as steroid-free options that are safe for long-term use, even on thin-skinned areas (face, groin, etc).
But there’s no proof Vtama 1% or Zoryve 0.3% is more effective than other topicals for psoriasis (steroids, calcipotriene, etc)...or that one is more effective than another.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote